These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2909562)

  • 1. Clinical experience with sotalol in patients with drug-refractory ventricular arrhythmias.
    Ruder MA; Ellis T; Lebsack C; Mead RH; Smith NA; Winkle RA
    J Am Coll Cardiol; 1989 Jan; 13(1):145-52. PubMed ID: 2909562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of electrophysiologically guided sotalol therapy for life-threatening ventricular arrhythmias.
    Lee RJ; Wong M; Siu A; Namekawa-Wong M; Epstein LM; Fitzpatrick AP; Grogin HR; Scheinman MM; Lesh MD
    Am Heart J; 1996 Nov; 132(5):973-8. PubMed ID: 8892770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
    Steinbeck G; Bach P; Haberl R
    J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.
    Nademanee K; Feld G; Hendrickson J; Singh PN; Singh BN
    Circulation; 1985 Sep; 72(3):555-64. PubMed ID: 4017207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia.
    Dorian P; Newman D; Berman N; Hardy J; Mitchell J
    J Am Coll Cardiol; 1993 Jul; 22(1):106-13. PubMed ID: 8509529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of sotalol for drug-refractory malignant ventricular arrhythmias.
    Gonzalez R; Scheinman MM; Herre JM; Griffin JC; Sauve MJ; Sharkey H
    J Am Coll Cardiol; 1988 Dec; 12(6):1568-72. PubMed ID: 3192854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia.
    Antz M; Cappato R; Kuck KH
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):627-35. PubMed ID: 8569226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest.
    Haverkamp W; Martinez-Rubio A; Hief C; Lammers A; Mühlenkamp S; Wichter T; Breithardt G; Borggrefe M
    J Am Coll Cardiol; 1997 Aug; 30(2):487-95. PubMed ID: 9247523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of sotalol guided by programmed electrical stimulation for sustained ventricular arrhythmias secondary to coronary artery disease.
    Young GD; Kerr CR; Mohama R; Boone J; Yeung-Lai-Wah JA
    Am J Cardiol; 1994 Apr; 73(9):677-82. PubMed ID: 8166065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts.
    Kuchar DL; Garan H; Venditti FJ; Finkelstein D; Rottman JN; McComb J; McGovern BA; Ruskin JN
    Am J Cardiol; 1989 Jul; 64(1):33-6. PubMed ID: 2741811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of d/l sotalol in patients with sustained ventricular tachycardia refractory to class I antiarrhythmic drugs.
    Kühlkamp V; Mermi J; Mewis C; Braun U; Seipel L
    Eur Heart J; 1995 Nov; 16(11):1625-31. PubMed ID: 8881857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral sotalol on systemic hemodynamics and programmed electrical stimulation in patients with ventricular arrhythmias and structural heart disease.
    Winters SL; Kukin M; Pe E; Stewart D; Deitchman D; Gomes JA
    Am J Cardiol; 1993 Aug; 72(4):38A-43A. PubMed ID: 8346725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and electrophysiologic effects of oral sotalol in patients with sustained ventricular tachycardia caused by coronary artery disease.
    Kus T; Campa MA; Nadeau R; Dubuc M; Kaltenbrunner W; Shenasa M
    Am Heart J; 1992 Jan; 123(1):82-9. PubMed ID: 1729853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease.
    Boriani G; Lubinski A; Capucci A; Niederle R; Kornacewicz-Jack Z; Wnuk-Wojnar AM; Borggrefe M; Brachmann J; Biffi M; Butrous GS;
    Eur Heart J; 2001 Dec; 22(23):2180-91. PubMed ID: 11913480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia.
    Wichter T; Borggrefe M; Haverkamp W; Chen X; Breithardt G
    Circulation; 1992 Jul; 86(1):29-37. PubMed ID: 1617780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose oral sotalol for monomorphic ventricular tachycardia: effects during programmed electrical stimulation and follow-up.
    Jordaens LJ; Palmer A; Clement DL
    Eur Heart J; 1989 Mar; 10(3):218-26. PubMed ID: 2707270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term reproducibility of electrophysiologically guided therapy with sotalol in patients with ventricular tachyarrhythmias.
    Mewis C; Kühlkamp V; Mermi J; Bosch RF; Seipel L
    J Am Coll Cardiol; 1999 Jun; 33(7):1989-95. PubMed ID: 10362204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of sotalol and procainamide in symptomatic ventricular tachycardia.
    Jordaens LJ; Colardyn F; Clement DL
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):155-61. PubMed ID: 2487531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sotalol: a new beta-adrenergic blocker for ventricular arrhythmias.
    Cavusoglu E; Frishman WH
    Prog Cardiovasc Dis; 1995; 37(6):423-40. PubMed ID: 7777671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.